CPC
COMPANY PROFILES
AND
CONFERENCES
 
 Welcome Guest

Currency:  Euro Dollor Pound  |  Cart  ( 0 ) items in cart
   
Search
Advanced search
 
BROWSE INDUSTRY


SignUp


Home Back Research Index Back Pharmaceuticals and Healthcare Back InfectoPharm Arzneimittel und Consilium GmbH - Strategic SWOT Analysis Review

InfectoPharm Arzneimittel und Consilium GmbH - Strategic SWOT Analysis Review

Enquire | Email | Print

 
Format PDF
ISBN GDPH214308SA
Published Date June 2014
No. of Pages 19
Select pricing :
Change Currency : EURO | $ USD | £ GBP
 
Bookmark and Share
 
Description
 
  • Abstract
  • Table of Contents

InfectoPharm Arzneimittel und Consilium GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

InfectoPharm Arzneimittel und Consilium GmbH (InfectoPharm) is a pharmaceutical company. It carries out the research, development, manufacture and marketing of medicines for pediatric infectious diseases. The company offers 75 products catering to the areas such as clinical infectious diseases, dermatology, pediatrics and pneumology. Its major product portfolio consists of oral antibiotics and antiparasitics. The company caters to the needs of children, pediatric physicians and adolescent patients. It also offers training services and education programs. The company also provides day nursery services, which are aimed at child welfare, child development and support to parents

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Section 1 - About the Company 5
InfectoPharm Arzneimittel und Consilium GmbH - Key Facts 5
InfectoPharm Arzneimittel und Consilium GmbH - Key Employees 6
InfectoPharm Arzneimittel und Consilium GmbH - Major Products and Services 7
InfectoPharm Arzneimittel und Consilium GmbH - History 8
InfectoPharm Arzneimittel und Consilium GmbH - Locations And Subsidiaries 9
Head Office 9
Section 2 – Company Analysis 10
InfectoPharm Arzneimittel und Consilium GmbH - Business Description 10
InfectoPharm Arzneimittel und Consilium GmbH - SWOT Analysis 11
SWOT Analysis - Overview 11
InfectoPharm Arzneimittel und Consilium GmbH - Strengths 11
Strength - Broad Portfolio of Products 11
Strength - Competitive Market Position 11
Strength - Sturdy Research and Development Activities 11
InfectoPharm Arzneimittel und Consilium GmbH - Weaknesses 11
Weakness - Limited Geographical Operations 11
InfectoPharm Arzneimittel und Consilium GmbH - Opportunities 11
Opportunity - Global Dermatology Market 11
Opportunity - Market Potential: Asthma 12
Opportunity - Product Approval – Mupirocin 12
InfectoPharm Arzneimittel und Consilium GmbH - Threats 12
Threat - Competition and Technological Changes 12
Threat - Uncertain R&D Outcomes 12
Threat - Increased Drug Scrutiny 13
InfectoPharm Arzneimittel und Consilium GmbH - Key Competitors 14
Section 3 – Company’s Lifesciences Financial Deals and Alliances 15
InfectoPharm Arzneimittel und Consilium GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 15
InfectoPharm Arzneimittel und Consilium GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014 17
InfectoPharm Arzneimittel und Consilium GmbH, Recent Deals Summary 18
Section 4 – Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables

InfectoPharm Arzneimittel und Consilium GmbH, Key Facts 5
InfectoPharm Arzneimittel und Consilium GmbH, Key Employees 6
InfectoPharm Arzneimittel und Consilium GmbH, Major Products and Services 7
InfectoPharm Arzneimittel und Consilium GmbH, History 8
InfectoPharm Arzneimittel und Consilium GmbH, Key Competitors 14
InfectoPharm Arzneimittel und Consilium GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 15
InfectoPharm Arzneimittel und Consilium GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014 17
InfectoPharm Arzneimittel und Consilium GmbH, Recent Deals Summary 18

List of Figures

InfectoPharm Arzneimittel und Consilium GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 15
InfectoPharm Arzneimittel und Consilium GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 17


Related reports
  

LeMaitre Vascular, Inc. (LMAT) - Financial and Strategic SWOT Analysis Review

  

Synergetics USA, Inc. (SURG) - Financial and Strategic SWOT Analysis Review

  

Nipro Corporation (8086) - Financial and Strategic SWOT Analysis Review

  

Shanghai Kehua Bio-engineering Co., Ltd. (002022) - Financial and Strategic SWOT Analysis Review

  

Moog Inc. (MOG.A) - Financial and Strategic SWOT Analysis Review

  

Positron Corporation (POSC) - Financial and Strategic SWOT Analysis Review

  

Smith & Nephew Plc (SN.) - Financial and Strategic SWOT Analysis Review


Bookmark With : Facebook Blogger MySpace Twitter Del.icio.us Reddit Furl WordProcess
 
Custom Research
If above report does not meet your requirements then you may avail our custom research service. We provide the most comprehensive, affordable, high-quality custom research which will match the exact topic and specifications of your choice. Please visit our Custom Research page to make an enquiry.
 
Product Id : 25581
INR 7695.575
GlobalData
 


RECENTLY VIEWED
 InfectoPharm Arzneimittel und Consilium GmbH - Strategic SWOT Analysis Review
 
We accept
Master Card Visa
Amex Discover
Paypal Diners Club
Mob +919223375060 / 919223767111
Fax: +91 22 27810778
E-mail:info@companyprofilesandconferences.com
Hours: Mon to Sat 8:00 AM to 8:00 PM IST